Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21360491 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Safety and Tolerability of Rituxan With Methotrexate and Etanercept or Methotrexate and Adalimumab in Patients With Active Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Biological: Rituximab;   Other: Placebo;   Drug: Methotrexate;   Drug: Etanercept;   Drug: Adalimumab;   Drug: Methylprednisolone;   Dietary Supplement: Folate;   Drug: Glucocorticoid

Indicates status has not been verified in more than two years